Examples: ICD M32, ICD R6521, ICD 8210, ICD 1970

C7A - ICD 10 Diagnosis Code - Malignant neuroendocrine tumors - Market Size, Prevalence, Incidence, Quality Outcomes, Top Hospitals & Physicians


Want to know more about Dexur's Capabilities? Get In Touch


ICD Code Description
C7A0 Malignant carcinoid tumors
C7A1 Malignant poorly differentiated neuroendocrine tumors
C7A8 Other malignant neuroendocrine tumors

Hospitalizations with C7A - Malignant neuroendocrine tumors - as a primary diagnosis code

  |  Back to Top

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

ICD Code ICD Description Total National Projected Hospitalizations - Annualized (Present on Admission - All) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) Total Medicare Hospitalization after Exclusion Avg. LOS Readmission Rate (%) Unplanned Readmission Rate (%) Total Medicare Payments Payment Per Day Payment Per Hospitalization Total Medicare Charges Avg. Charges Mortality Rate (%) SNF Discharge Rate (%) Home Discharge Rate (%)
C7A8 Other malignant neuroendocrine tumors 14.77
C7A1 Malignant poorly differentiated neuroendocrine tumors 17.68

Hospitalizations with C7A - Malignant neuroendocrine tumors - as a primary or secondary diagnosis code

  |  Back to Top

*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.

ICD Code ICD Description Total National Projected Hospitalizations - Annualized (Present on Admission - All) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) Total Medicare Hospitalization after Exclusion Avg. LOS Readmission Rate (%) Unplanned Readmission Rate (%) Total Medicare Payments Payment Per Day Payment Per Hospitalization Total Medicare Charges Avg. Charges Mortality Rate (%) SNF Discharge Rate (%) Home Discharge Rate (%)
C7A8 Other malignant neuroendocrine tumors 6.87 27.42
C7A1 Malignant poorly differentiated neuroendocrine tumors 7.37 29.36